# Proton Therapy With Capecitabine for Rectal Cancer

> **NCT00503932** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **M.D. Anderson Cancer Center**

## Conditions studied

- Rectal Cancer

## Interventions

- **PROCEDURE:** Proton Therapy
- **DRUG:** Capecitabine

## Key facts

- **NCT ID:** NCT00503932
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-07
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participant enrollment.
- **Last updated:** 2012-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00503932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00503932, "Proton Therapy With Capecitabine for Rectal Cancer". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00503932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*